Reply to Bombard and Mighton

Affiliations

¹ Egenis, University of Exeter, Exeter, UK.
² Centre for Research Ethics and Bioethics, Uppsala University, Uppsala, Sweden.
³ Society & Ethics Research, Connecting Science, Wellcome Genome Campus, Cambridge, UK.
⁴ School of Medicine, Cardiff University, Cardiff, UK.
⁵ Landspitali - the National University Hospital of Iceland, Department of Genetics and Molecular Medicine, Reykjavík, Iceland.
⁶ Amsterdam UMC, Vrije Universiteit Amsterdam, Department of Clinical Genetics, Section Community Genetics, Amsterdam Public Health research Institute, Amsterdam, The Netherlands.
⁷ Clinical Genetics Department, Guy's & St Thomas' NHS Foundation Trust, London, UK. Francesca.Forzano@gstt.nhs.uk.

Comment

Daniele Carrieri et al. Eur J Hum Genet. 2019 Apr.

. 2019 Apr;27(4):507-508.

doi: 10.1038/s41431-018-0315-z. Epub 2019 Jan 18.

¹ Egenis, University of Exeter, Exeter, UK.
² Centre for Research Ethics and Bioethics, Uppsala University, Uppsala, Sweden.
³ Society & Ethics Research, Connecting Science, Wellcome Genome Campus, Cambridge, UK.
⁴ School of Medicine, Cardiff University, Cardiff, UK.
⁵ Landspitali - the National University Hospital of Iceland, Department of Genetics and Molecular Medicine, Reykjavík, Iceland.
⁶ Amsterdam UMC, Vrije Universiteit Amsterdam, Department of Clinical Genetics, Section Community Genetics, Amsterdam Public Health research Institute, Amsterdam, The Netherlands.
⁷ Clinical Genetics Department, Guy's & St Thomas' NHS Foundation Trust, London, UK. Francesca.Forzano@gstt.nhs.uk.

No abstract available

Conflict of interest statement

The authors declare that they have no conflict of interest.

Recontacting in clinical practice: an investigation of the views of healthcare professionals and clinical scientists in the United Kingdom.
Carrieri D, Dheensa S, Doheny S, Clarke AJ, Turnpenny PD, Lucassen AM, Kelly SE. Carrieri D, et al. Eur J Hum Genet. 2017 Feb;25(3):275-279. doi: 10.1038/ejhg.2016.188. Epub 2017 Jan 4. Eur J Hum Genet. 2017. PMID: 28051074 Free PMC article.
Recontacting clinical genetics patients with reclassified results: equity and policy challenges.
Bombard Y, Mighton C. Bombard Y, et al. Eur J Hum Genet. 2019 Apr;27(4):505-506. doi: 10.1038/s41431-018-0313-1. Eur J Hum Genet. 2019. PMID: 30568242 Free PMC article. No abstract available.

1. Sirchia F, Carrieri D, Dheensa S, et al. Recontacting or not recontacting? A survey of current practices in clinical genetics centres in Europe. Eur J Hum Genet. 2018;26:946–54. doi: 10.1038/s41431-018-0131-5. - DOI - PMC - PubMed
1. Lesko LJ, Zineh I, Huang SM. What is clinical utility and why should we care? Clin Pharmacol Ther. 2010;88:729–33. doi: 10.1038/clpt.2010.229. - DOI - PubMed
1. Grosse SD, Khoury MJ. What is the clinical utility of genetic testing? Genet Med. 2006;8:448–50. doi: 10.1097/01.gim.0000227935.26763.c6. - DOI - PubMed